Kimberly Blackwell, M.D., has been leading Zentalis Pharmaceuticals, Inc. as the CEO since May 2022. She has a strong background in medicine, holding an M.D. from Mayo Clinic Medical School. Before taking the helm at Zentalis, she worked as the...
Kimberly Blackwell, M.D., has been leading Zentalis Pharmaceuticals, Inc. as the CEO since May 2022. She has a strong background in medicine, holding an M.D. from Mayo Clinic Medical School. Before taking the helm at Zentalis, she worked as the Chief Medical Officer at Tempus Labs, where she contributed to advancements in precision medicine through AI. Her previous roles include Vice President of Early-Stage Oncology at Eli Lilly, where she directed clinical teams on early-phase cancer treatments. At Duke University, she oversaw women's cancer research for nearly two decades, demonstrating her commitment to healthcare and education.